Calcium channel blocker nimodipine (Nimotop) in the treatment of soft cognitive disturbances
The article is dedicated to the problem of the calcium channel blockers use for treatment of hypertensive patients with cognitive dysfunction. In neurological practice, the well-studied representative of this group is Nimodipine (Nimotop), which was associated with the main hope in the treatment of such patients. Moreover, there is the possibility of nimodipine use in cardiology practice, in particular in patients with coronary heart disease.

Keywords: Nimodipine, calcium channel blockers, hypertension, cognitive impairment